The Committee for Medicinal Products for Human Use reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU

BioArctic Sweden

View original content:https://www.prnewswire.co.uk/news-releases/the-committee-for-medicinal-products-for-human-use-chmp-reaffirms-positive-opinion-for-lecanemab-in-early-alzheimers-disease-in-the-eu-302388577.html